Follicular leukoderma is an early step in the course of ordinary vitiligo: A new hypothesis
DOI:
https://doi.org/10.66344/jpad.v32i2.1894Abstract
Background Hair follicle is the primary target of many skin diseases. Vitiligo is a well-known autoimmune disease where the basal melanocytes of epidermis are attacked by the immunological reactions. Recently we had shown that the ordinary vitiligo might start initially in the hair follicles.
Methods Ninety patients with vitiligo having follicular leukoderma were involved during the period from 2014-21. Clinical and Wood’s lamp examination were done to confirm vitiligo and exclude other hypopigmented diseases. Also, Skin biopsies for 10 cases with white follicular lesions and black hair were performed and stained with Haematoxylin-Eosin and immunohistochemical stains (HMB-45 and melan A) to evaluate histopathological changes.
Results 90 patients were analysed. Their ages ranged from 4-40 years with a mean of 20±4 years. Clinical and Wood’s lamp examination showed that all patients had follicular white minute macules in early course of the disease that gradually coalesced into larger white macules and patches at the same sites. Histopathological examination including using immunohistochemical stain showed absent melanocytes in the hair follicle infundibulum and the adjacent basal layer of epidermis, perifollicular lymphocytic infiltrates and areas of focal invasion of follicular epithelium and the surrounding epidermis. In addition, superficial and to a lesser extent deep perivascular lymphocytic infiltrates were observed.
Conclusion Ordinary vitiligo initially starts as follicular leukoderma without necessarily causing leukotrichia, then these macules coalesce into larger vitiliginous patches.
References
1. Sharquie KE. The histology and immunopathology of vitiligo. PhD Thesis 1981.
2. Sharquie KE. Vitiligo. Clinical Exp Dermatol. 1984;9:117-26.
3. Bolognia JL and Pawelek JM. Biology of hypopigmentation. J Am Acad Dermatol. 1988;19:217-55.
4. Sharquie KE. Vitiligo in Iraq. Iraqi Med J. 1987;35:31-2.
5. Gauthier Y, Cario-Andre M, Lepreux S, et al. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol. 2003;148:95-101.
6. Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. New Eng J Med. 2010;362:1686-97.
7. Taher ZA, Lauzon G, Maguiness S, et al. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Br J Dermatol. 2009;161:654-9.
8. Bassiouny DA and Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol. 2011;36:292-7.
9. Dwivedi M, Laddha NC, Arora P, et al. Decreased regulatory T-cells and CD4(+)/CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo. Pigment Cell Melanoma Res. 2013;26:586-91.
10. Krause K and Foitzik K. Biology of the hair follicle: the basics. Semin Cutan Med Surg. 2006;25:2-10.
11. Vinay K and Dogra S. Stem cells in vitiligo: Current position and prospects. Pigment Int. 2014;1:8-12.
12. Cui J, Shen LY and Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol. 1991;97:410-6.
13. Ezzedine K, Amazan E, Seneschal J, et al. Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res. 2012;25:527-9.
14. Gan EY, Cario-Andre M, Pain C, et al. Follicular vitiligo: A report of 8 cases. J Am Acad Dermatol. 2016;74:1178-84.
15. Sharquie K.E and Noaimi AA. Follicular vitiligo: the present clinical status. Our Dermatol Online. 2016;2:176-8.
16. Sharquie K.E, Sharquie I.K and Al Hamza A.N. Psoriasis, pityriasis alba, and vitiligo (PPV) are a triad of one disease: New observation. Our Dermatol Online. 2021;12: 314-23.
17. Falabella R. Vitiligo and the melanocyte reservoir. Indian J Dermatol. 2009;54:313-8.
18. Sonthalia S, Sarkar R and Arora R. Novel dermoscopic findings of perifollicular depigmentation and evolving leukotrichia in areas of clinically unaltered pigmentation: An early predictive sign of impending vitiligo. Pigment Int. 2014;1:28-30.
19. Montes LF, Abulafia J, Wilborn WH, et al. Value of histopathology in vitiligo. Int J Dermatol. 2003;42:57-61.
20. Hann SK, Park YK, Lee KG, et al. Epidermal changes in active vitiligo. J Dermatol. 1992;19:217-22.
21. Sharquie KE, Mehenna SH, Naji AA, et al. Inflammatory Changes in Vitiligo: Stage I and II Depigmentation. Am J Dermatopathol. 2004;26:108-12.
22. Anbar TS, Abdel-Raouf H, Awad SS, et al. The hair follicle melanocytes in vitiligo in relation to disease duration. J Eur Acad Dermatol Venereol. 2009;23:934-9.
23. Anbar Tel D, Abdel-Raouf H, Awad SS, et al. Perifollicular inflammatory infiltrate in vitiligo. Int J Dermatol. 2011;50:234-7.
24. Van Neste D and Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron. 2004;35:193-200.
25. Sharquie K.E, Noaimi AA and Mijthab ZM. Chronic Scalp Folliculitis versus Acne Vulgaris (Observational Case Series Study). J Clin Experiment Dermatol Res. 2012;3.
26. Thomas M and Khopkar US. Keratosis pilaris revisited: is it more than just a follicular keratosis? Int J Trichol. 2012;4:255-8.
27. Sharquie KE, Noaimi AA and Hameed AF. Lichen Planopilaris is a Common Scarring Alopecia among Iraqi Population. J cosmet Dermatol Sci Appl. 2013:35-9.
28. Walker A, Mesinkovska NA, Boncher J, et al. Colocalization of vitiligo and alopecia areata presenting as poliosis. J Cutan Pathol. 2015;42:150-4.
29. Baibergenova A and Donovan J. Lichen planopilaris: update on pathogenesis and treatment. Skinmed. 2013;11:161-5.
30. Eshiba S, Namiki T, Mohri Y, et al. Stem cell spreading dynamics intrinsically differentiate acral melanomas from nevi. Cell Rep. 2021;36:109492.
31. Jang YH, Kim SL, Lee JS, et al. Possible existence of melanocytes or melanoblasts in human sebaceous glands. Ann Dermatol. 2014;26:469-73.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Sharquie, K.E. , Al Hamza, A.N, Sharquie, I. K
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
